img

Global RNA Vaccines Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global RNA Vaccines Market Research Report 2024

RNA is a rather versatile technology and offers a number of advantages. RNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes RNA especially attractive for vaccines and gene editing. RNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of RNA has greatly favored the development of in vivo transfection strategies.
RNA Vaccines & Therapeutics is in the development stage and there is no use in the market. The fastest research is Clinical phrase II, such as AGS-004 of Argos Therapeutics, SB-FIX, SB-318, SB-913 of Sangamo Therapeutics. The major application of RNA Vaccines & Therapeutics is for infectious disease, cancer and others. And infectious disease and cancer are the major applications.
According to Mr Accuracy reports’s new survey, global RNA Vaccines market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole RNA Vaccines market research.
Key manufacturers engaged in the RNA Vaccines industry include Moderna Therapeutics, CureVac, Translate Bio, BioNTech, Sangamo Therapeutics, Argos Therapeutics, In-Cell-Art, eTheRNA and Ethris, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of RNA Vaccines were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole RNA Vaccines market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global RNA Vaccines market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology
Segment by Type
Individualized Cancer Treatment MRNA Vaccine
Infectious Disease Treatment MRNA Vaccine
Infection Prevention MRNA Vaccine

Segment by Application


Infectious Disease
Cancer
Other

Consumption by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The RNA Vaccines report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 RNA Vaccines Market Overview
1.1 Product Overview and Scope of RNA Vaccines
1.2 RNA Vaccines Segment by Type
1.2.1 Global RNA Vaccines Market Value Comparison by Type (2024-2034)
1.2.2 Individualized Cancer Treatment MRNA Vaccine
1.2.3 Infectious Disease Treatment MRNA Vaccine
1.2.4 Infection Prevention MRNA Vaccine
1.3 RNA Vaccines Segment by Application
1.3.1 Global RNA Vaccines Market Value by Application: (2024-2034)
1.3.2 Infectious Disease
1.3.3 Cancer
1.3.4 Other
1.4 Global RNA Vaccines Market Size Estimates and Forecasts
1.4.1 Global RNA Vaccines Revenue 2024-2034
1.4.2 Global RNA Vaccines Sales 2024-2034
1.4.3 Global RNA Vaccines Market Average Price (2024-2034)
1.5 Assumptions and Limitations
2 RNA Vaccines Market Competition by Manufacturers
2.1 Global RNA Vaccines Sales Market Share by Manufacturers (2024-2024)
2.2 Global RNA Vaccines Revenue Market Share by Manufacturers (2024-2024)
2.3 Global RNA Vaccines Average Price by Manufacturers (2024-2024)
2.4 Global RNA Vaccines Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of RNA Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of RNA Vaccines, Product Type & Application
2.7 RNA Vaccines Market Competitive Situation and Trends
2.7.1 RNA Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest RNA Vaccines Players Market Share by Revenue
2.7.3 Global RNA Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 RNA Vaccines Retrospective Market Scenario by Region
3.1 Global RNA Vaccines Market Size by Region: 2024 Versus 2022 Versus 2034
3.2 Global RNA Vaccines Global RNA Vaccines Sales by Region: 2024-2034
3.2.1 Global RNA Vaccines Sales by Region: 2024-2024
3.2.2 Global RNA Vaccines Sales by Region: 2024-2034
3.3 Global RNA Vaccines Global RNA Vaccines Revenue by Region: 2024-2034
3.3.1 Global RNA Vaccines Revenue by Region: 2024-2024
3.3.2 Global RNA Vaccines Revenue by Region: 2024-2034
3.4 North America RNA Vaccines Market Facts & Figures by Country
3.4.1 North America RNA Vaccines Market Size by Country: 2024 VS 2022 VS 2034
3.4.2 North America RNA Vaccines Sales by Country (2024-2034)
3.4.3 North America RNA Vaccines Revenue by Country (2024-2034)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe RNA Vaccines Market Facts & Figures by Country
3.5.1 Europe RNA Vaccines Market Size by Country: 2024 VS 2022 VS 2034
3.5.2 Europe RNA Vaccines Sales by Country (2024-2034)
3.5.3 Europe RNA Vaccines Revenue by Country (2024-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific RNA Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific RNA Vaccines Market Size by Country: 2024 VS 2022 VS 2034
3.6.2 Asia Pacific RNA Vaccines Sales by Country (2024-2034)
3.6.3 Asia Pacific RNA Vaccines Revenue by Country (2024-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America RNA Vaccines Market Facts & Figures by Country
3.7.1 Latin America RNA Vaccines Market Size by Country: 2024 VS 2022 VS 2034
3.7.2 Latin America RNA Vaccines Sales by Country (2024-2034)
3.7.3 Latin America RNA Vaccines Revenue by Country (2024-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa RNA Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa RNA Vaccines Market Size by Country: 2024 VS 2022 VS 2034
3.8.2 Middle East and Africa RNA Vaccines Sales by Country (2024-2034)
3.8.3 Middle East and Africa RNA Vaccines Revenue by Country (2024-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global RNA Vaccines Sales by Type (2024-2034)
4.1.1 Global RNA Vaccines Sales by Type (2024-2024)
4.1.2 Global RNA Vaccines Sales by Type (2024-2034)
4.1.3 Global RNA Vaccines Sales Market Share by Type (2024-2034)
4.2 Global RNA Vaccines Revenue by Type (2024-2034)
4.2.1 Global RNA Vaccines Revenue by Type (2024-2024)
4.2.2 Global RNA Vaccines Revenue by Type (2024-2034)
4.2.3 Global RNA Vaccines Revenue Market Share by Type (2024-2034)
4.3 Global RNA Vaccines Price by Type (2024-2034)
5 Segment by Application
5.1 Global RNA Vaccines Sales by Application (2024-2034)
5.1.1 Global RNA Vaccines Sales by Application (2024-2024)
5.1.2 Global RNA Vaccines Sales by Application (2024-2034)
5.1.3 Global RNA Vaccines Sales Market Share by Application (2024-2034)
5.2 Global RNA Vaccines Revenue by Application (2024-2034)
5.2.1 Global RNA Vaccines Revenue by Application (2024-2024)
5.2.2 Global RNA Vaccines Revenue by Application (2024-2034)
5.2.3 Global RNA Vaccines Revenue Market Share by Application (2024-2034)
5.3 Global RNA Vaccines Price by Application (2024-2034)
6 Key Companies Profiled
6.1 Moderna Therapeutics
6.1.1 Moderna Therapeutics Corporation Information
6.1.2 Moderna Therapeutics Description and Business Overview
6.1.3 Moderna Therapeutics RNA Vaccines Sales, Revenue and Gross Margin (2024-2024)
6.1.4 Moderna Therapeutics RNA Vaccines Product Portfolio
6.1.5 Moderna Therapeutics Recent Developments/Updates
6.2 CureVac
6.2.1 CureVac Corporation Information
6.2.2 CureVac Description and Business Overview
6.2.3 CureVac RNA Vaccines Sales, Revenue and Gross Margin (2024-2024)
6.2.4 CureVac RNA Vaccines Product Portfolio
6.2.5 CureVac Recent Developments/Updates
6.3 Translate Bio
6.3.1 Translate Bio Corporation Information
6.3.2 Translate Bio Description and Business Overview
6.3.3 Translate Bio RNA Vaccines Sales, Revenue and Gross Margin (2024-2024)
6.3.4 Translate Bio RNA Vaccines Product Portfolio
6.3.5 Translate Bio Recent Developments/Updates
6.4 BioNTech
6.4.1 BioNTech Corporation Information
6.4.2 BioNTech Description and Business Overview
6.4.3 BioNTech RNA Vaccines Sales, Revenue and Gross Margin (2024-2024)
6.4.4 BioNTech RNA Vaccines Product Portfolio
6.4.5 BioNTech Recent Developments/Updates
6.5 Sangamo Therapeutics
6.5.1 Sangamo Therapeutics Corporation Information
6.5.2 Sangamo Therapeutics Description and Business Overview
6.5.3 Sangamo Therapeutics RNA Vaccines Sales, Revenue and Gross Margin (2024-2024)
6.5.4 Sangamo Therapeutics RNA Vaccines Product Portfolio
6.5.5 Sangamo Therapeutics Recent Developments/Updates
6.6 Argos Therapeutics
6.6.1 Argos Therapeutics Corporation Information
6.6.2 Argos Therapeutics Description and Business Overview
6.6.3 Argos Therapeutics RNA Vaccines Sales, Revenue and Gross Margin (2024-2024)
6.6.4 Argos Therapeutics RNA Vaccines Product Portfolio
6.6.5 Argos Therapeutics Recent Developments/Updates
6.7 In-Cell-Art
6.6.1 In-Cell-Art Corporation Information
6.6.2 In-Cell-Art Description and Business Overview
6.6.3 In-Cell-Art RNA Vaccines Sales, Revenue and Gross Margin (2024-2024)
6.4.4 In-Cell-Art RNA Vaccines Product Portfolio
6.7.5 In-Cell-Art Recent Developments/Updates
6.8 eTheRNA
6.8.1 eTheRNA Corporation Information
6.8.2 eTheRNA Description and Business Overview
6.8.3 eTheRNA RNA Vaccines Sales, Revenue and Gross Margin (2024-2024)
6.8.4 eTheRNA RNA Vaccines Product Portfolio
6.8.5 eTheRNA Recent Developments/Updates
6.9 Ethris
6.9.1 Ethris Corporation Information
6.9.2 Ethris Description and Business Overview
6.9.3 Ethris RNA Vaccines Sales, Revenue and Gross Margin (2024-2024)
6.9.4 Ethris RNA Vaccines Product Portfolio
6.9.5 Ethris Recent Developments/Updates
6.10 Tiba Biotechnology
6.10.1 Tiba Biotechnology Corporation Information
6.10.2 Tiba Biotechnology Description and Business Overview
6.10.3 Tiba Biotechnology RNA Vaccines Sales, Revenue and Gross Margin (2024-2024)
6.10.4 Tiba Biotechnology RNA Vaccines Product Portfolio
6.10.5 Tiba Biotechnology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 RNA Vaccines Industry Chain Analysis
7.2 RNA Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 RNA Vaccines Production Mode & Process
7.4 RNA Vaccines Sales and Marketing
7.4.1 RNA Vaccines Sales Channels
7.4.2 RNA Vaccines Distributors
7.5 RNA Vaccines Customers
8 RNA Vaccines Market Dynamics
8.1 RNA Vaccines Industry Trends
8.2 RNA Vaccines Market Drivers
8.3 RNA Vaccines Market Challenges
8.4 RNA Vaccines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global RNA Vaccines Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global RNA Vaccines Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global RNA Vaccines Market Competitive Situation by Manufacturers in 2022
Table 4. Global RNA Vaccines Sales (K Doses) of Key Manufacturers (2024-2024)
Table 5. Global RNA Vaccines Sales Market Share by Manufacturers (2024-2024)
Table 6. Global RNA Vaccines Revenue (US$ Million) by Manufacturers (2024-2024)
Table 7. Global RNA Vaccines Revenue Share by Manufacturers (2024-2024)
Table 8. Global Market RNA Vaccines Average Price (USD/Dose) of Key Manufacturers (2024-2024)
Table 9. Global Key Players of RNA Vaccines, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of RNA Vaccines, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of RNA Vaccines, Product Type & Application
Table 12. Global Key Manufacturers of RNA Vaccines, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global RNA Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RNA Vaccines as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global RNA Vaccines Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Table 17. Global RNA Vaccines Sales by Region (2024-2024) & (K Doses)
Table 18. Global RNA Vaccines Sales Market Share by Region (2024-2024)
Table 19. Global RNA Vaccines Sales by Region (2024-2034) & (K Doses)
Table 20. Global RNA Vaccines Sales Market Share by Region (2024-2034)
Table 21. Global RNA Vaccines Revenue by Region (2024-2024) & (US$ Million)
Table 22. Global RNA Vaccines Revenue Market Share by Region (2024-2024)
Table 23. Global RNA Vaccines Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global RNA Vaccines Revenue Market Share by Region (2024-2034)
Table 25. North America RNA Vaccines Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 26. North America RNA Vaccines Sales by Country (2024-2024) & (K Doses)
Table 27. North America RNA Vaccines Sales by Country (2024-2034) & (K Doses)
Table 28. North America RNA Vaccines Revenue by Country (2024-2024) & (US$ Million)
Table 29. North America RNA Vaccines Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe RNA Vaccines Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 31. Europe RNA Vaccines Sales by Country (2024-2024) & (K Doses)
Table 32. Europe RNA Vaccines Sales by Country (2024-2034) & (K Doses)
Table 33. Europe RNA Vaccines Revenue by Country (2024-2024) & (US$ Million)
Table 34. Europe RNA Vaccines Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific RNA Vaccines Revenue by Region: 2024 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific RNA Vaccines Sales by Region (2024-2024) & (K Doses)
Table 37. Asia Pacific RNA Vaccines Sales by Region (2024-2034) & (K Doses)
Table 38. Asia Pacific RNA Vaccines Revenue by Region (2024-2024) & (US$ Million)
Table 39. Asia Pacific RNA Vaccines Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America RNA Vaccines Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America RNA Vaccines Sales by Country (2024-2024) & (K Doses)
Table 42. Latin America RNA Vaccines Sales by Country (2024-2034) & (K Doses)
Table 43. Latin America RNA Vaccines Revenue by Country (2024-2024) & (US$ Million)
Table 44. Latin America RNA Vaccines Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa RNA Vaccines Revenue by Country: 2024 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa RNA Vaccines Sales by Country (2024-2024) & (K Doses)
Table 47. Middle East & Africa RNA Vaccines Sales by Country (2024-2034) & (K Doses)
Table 48. Middle East & Africa RNA Vaccines Revenue by Country (2024-2024) & (US$ Million)
Table 49. Middle East & Africa RNA Vaccines Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global RNA Vaccines Sales (K Doses) by Type (2024-2024)
Table 51. Global RNA Vaccines Sales (K Doses) by Type (2024-2034)
Table 52. Global RNA Vaccines Sales Market Share by Type (2024-2024)
Table 53. Global RNA Vaccines Sales Market Share by Type (2024-2034)
Table 54. Global RNA Vaccines Revenue (US$ Million) by Type (2024-2024)
Table 55. Global RNA Vaccines Revenue (US$ Million) by Type (2024-2034)
Table 56. Global RNA Vaccines Revenue Market Share by Type (2024-2024)
Table 57. Global RNA Vaccines Revenue Market Share by Type (2024-2034)
Table 58. Global RNA Vaccines Price (USD/Dose) by Type (2024-2024)
Table 59. Global RNA Vaccines Price (USD/Dose) by Type (2024-2034)
Table 60. Global RNA Vaccines Sales (K Doses) by Application (2024-2024)
Table 61. Global RNA Vaccines Sales (K Doses) by Application (2024-2034)
Table 62. Global RNA Vaccines Sales Market Share by Application (2024-2024)
Table 63. Global RNA Vaccines Sales Market Share by Application (2024-2034)
Table 64. Global RNA Vaccines Revenue (US$ Million) by Application (2024-2024)
Table 65. Global RNA Vaccines Revenue (US$ Million) by Application (2024-2034)
Table 66. Global RNA Vaccines Revenue Market Share by Application (2024-2024)
Table 67. Global RNA Vaccines Revenue Market Share by Application (2024-2034)
Table 68. Global RNA Vaccines Price (USD/Dose) by Application (2024-2024)
Table 69. Global RNA Vaccines Price (USD/Dose) by Application (2024-2034)
Table 70. Moderna Therapeutics Corporation Information
Table 71. Moderna Therapeutics Description and Business Overview
Table 72. Moderna Therapeutics RNA Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2024-2024)
Table 73. Moderna Therapeutics RNA Vaccines Product
Table 74. Moderna Therapeutics Recent Developments/Updates
Table 75. CureVac Corporation Information
Table 76. CureVac Description and Business Overview
Table 77. CureVac RNA Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2024-2024)
Table 78. CureVac RNA Vaccines Product
Table 79. CureVac Recent Developments/Updates
Table 80. Translate Bio Corporation Information
Table 81. Translate Bio Description and Business Overview
Table 82. Translate Bio RNA Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2024-2024)
Table 83. Translate Bio RNA Vaccines Product
Table 84. Translate Bio Recent Developments/Updates
Table 85. BioNTech Corporation Information
Table 86. BioNTech Description and Business Overview
Table 87. BioNTech RNA Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2024-2024)
Table 88. BioNTech RNA Vaccines Product
Table 89. BioNTech Recent Developments/Updates
Table 90. Sangamo Therapeutics Corporation Information
Table 91. Sangamo Therapeutics Description and Business Overview
Table 92. Sangamo Therapeutics RNA Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2024-2024)
Table 93. Sangamo Therapeutics RNA Vaccines Product
Table 94. Sangamo Therapeutics Recent Developments/Updates
Table 95. Argos Therapeutics Corporation Information
Table 96. Argos Therapeutics Description and Business Overview
Table 97. Argos Therapeutics RNA Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2024-2024)
Table 98. Argos Therapeutics RNA Vaccines Product
Table 99. Argos Therapeutics Recent Developments/Updates
Table 100. In-Cell-Art Corporation Information
Table 101. In-Cell-Art Description and Business Overview
Table 102. In-Cell-Art RNA Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2024-2024)
Table 103. In-Cell-Art RNA Vaccines Product
Table 104. In-Cell-Art Recent Developments/Updates
Table 105. eTheRNA Corporation Information
Table 106. eTheRNA Description and Business Overview
Table 107. eTheRNA RNA Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2024-2024)
Table 108. eTheRNA RNA Vaccines Product
Table 109. eTheRNA Recent Developments/Updates
Table 110. Ethris Corporation Information
Table 111. Ethris Description and Business Overview
Table 112. Ethris RNA Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2024-2024)
Table 113. Ethris RNA Vaccines Product
Table 114. Ethris Recent Developments/Updates
Table 115. Tiba Biotechnology Corporation Information
Table 116. Tiba Biotechnology Description and Business Overview
Table 117. Tiba Biotechnology RNA Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2024-2024)
Table 118. Tiba Biotechnology RNA Vaccines Product
Table 119. Tiba Biotechnology Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. RNA Vaccines Distributors List
Table 123. RNA Vaccines Customers List
Table 124. RNA Vaccines Market Trends
Table 125. RNA Vaccines Market Drivers
Table 126. RNA Vaccines Market Challenges
Table 127. RNA Vaccines Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of RNA Vaccines
Figure 2. Global RNA Vaccines Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global RNA Vaccines Market Share by Type in 2022 & 2034
Figure 4. Individualized Cancer Treatment MRNA Vaccine Product Picture
Figure 5. Infectious Disease Treatment MRNA Vaccine Product Picture
Figure 6. Infection Prevention MRNA Vaccine Product Picture
Figure 7. Global RNA Vaccines Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 8. Global RNA Vaccines Market Share by Application in 2022 & 2034
Figure 9. Infectious Disease
Figure 10. Cancer
Figure 11. Other
Figure 12. Global RNA Vaccines Revenue, (US$ Million), 2024 VS 2022 VS 2034
Figure 13. Global RNA Vaccines Market Size (2024-2034) & (US$ Million)
Figure 14. Global RNA Vaccines Sales (2024-2034) & (K Doses)
Figure 15. Global RNA Vaccines Average Price (USD/Dose) & (2024-2034)
Figure 16. RNA Vaccines Report Years Considered
Figure 17. RNA Vaccines Sales Share by Manufacturers in 2022
Figure 18. Global RNA Vaccines Revenue Share by Manufacturers in 2022
Figure 19. The Global 5 and 10 Largest RNA Vaccines Players: Market Share by Revenue in 2022
Figure 20. RNA Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 21. Global RNA Vaccines Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Figure 22. North America RNA Vaccines Sales Market Share by Country (2024-2034)
Figure 23. North America RNA Vaccines Revenue Market Share by Country (2024-2034)
Figure 24. U.S. RNA Vaccines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 25. Canada RNA Vaccines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 26. Europe RNA Vaccines Sales Market Share by Country (2024-2034)
Figure 27. Europe RNA Vaccines Revenue Market Share by Country (2024-2034)
Figure 28. Germany RNA Vaccines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 29. France RNA Vaccines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 30. U.K. RNA Vaccines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 31. Italy RNA Vaccines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 32. Russia RNA Vaccines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 33. Asia Pacific RNA Vaccines Sales Market Share by Region (2024-2034)
Figure 34. Asia Pacific RNA Vaccines Revenue Market Share by Region (2024-2034)
Figure 35. China RNA Vaccines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 36. Japan RNA Vaccines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 37. South Korea RNA Vaccines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 38. India RNA Vaccines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 39. Australia RNA Vaccines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 40. Taiwan RNA Vaccines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 41. Indonesia RNA Vaccines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 42. Thailand RNA Vaccines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 43. Malaysia RNA Vaccines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 44. Philippines RNA Vaccines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 45. Latin America RNA Vaccines Sales Market Share by Country (2024-2034)
Figure 46. Latin America RNA Vaccines Revenue Market Share by Country (2024-2034)
Figure 47. Mexico RNA Vaccines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 48. Brazil RNA Vaccines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 49. Argentina RNA Vaccines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 50. Middle East & Africa RNA Vaccines Sales Market Share by Country (2024-2034)
Figure 51. Middle East & Africa RNA Vaccines Revenue Market Share by Country (2024-2034)
Figure 52. Turkey RNA Vaccines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 53. Saudi Arabia RNA Vaccines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 54. U.A.E RNA Vaccines Revenue Growth Rate (2024-2034) & (US$ Million)
Figure 55. Global Sales Market Share of RNA Vaccines by Type (2024-2034)
Figure 56. Global Revenue Market Share of RNA Vaccines by Type (2024-2034)
Figure 57. Global RNA Vaccines Price (USD/Dose) by Type (2024-2034)
Figure 58. Global Sales Market Share of RNA Vaccines by Application (2024-2034)
Figure 59. Global Revenue Market Share of RNA Vaccines by Application (2024-2034)
Figure 60. Global RNA Vaccines Price (USD/Dose) by Application (2024-2034)
Figure 61. RNA Vaccines Value Chain
Figure 62. RNA Vaccines Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries